Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly from Positive Blood Culture Bottles.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
23 03 2023
Historique:
pubmed: 1 3 2023
medline: 28 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

The rapid administration of optimal antimicrobial treatment is paramount for the treatment of bloodstream infections (BSIs), and rapid antimicrobial susceptibility testing (AST) results are essential. Q-linea has developed the ASTar system, a rapid phenotypic AST device. Here, we report the performance of the ASTar BC G- (Gram-negative) kit when assessed according to the ISO 20776-2:2007 standard for performance evaluation of

Identifiants

pubmed: 36852983
doi: 10.1128/jcm.01525-22
pmc: PMC10035315
doi:

Substances chimiques

Anti-Bacterial Agents 0
Reagent Kits, Diagnostic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0152522

Références

JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Open Forum Infect Dis. 2020 Sep 30;7(11):ofaa461
pubmed: 33209951
Crit Care Med. 2010 Apr;38(4):1045-53
pubmed: 20048677
Front Cell Infect Microbiol. 2020 Jul 15;10:308
pubmed: 32760676
JAMA Netw Open. 2020 Apr 1;3(4):e202899
pubmed: 32297949
Cochrane Database Syst Rev. 2021 May 4;5:CD013235
pubmed: 34097767
Scand J Trauma Resusc Emerg Med. 2019 Feb 14;27(1):19
pubmed: 30764843
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29109168
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1573-1583
pubmed: 29808350
Clin Microbiol Rev. 2016 Jan;29(1):59-103
pubmed: 26598385
J Infect. 2017 Feb;74(2):107-117
pubmed: 27884733
Clin Microbiol Infect. 2013 Jun;19(6):501-9
pubmed: 23473333
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Crit Care. 2015 Feb 16;19:63
pubmed: 25888181
Pharmacotherapy. 2015 Mar;35(3):269-76
pubmed: 25809178
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605

Auteurs

J Göransson (J)

Q-linea AB, Uppsala, Sweden.

M Sundqvist (M)

Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

E Ghaderi (E)

Department of Bacteriology, Uppsala University Hospital, Uppsala, Sweden.

J G Lisby (JG)

Department of Clinical Microbiology, University of Copenhagen, Hvidovre Hospital, Hvidovre, Denmark.

Y Molin (Y)

Q-linea AB, Uppsala, Sweden.

E Eriksson (E)

Q-linea AB, Uppsala, Sweden.

S Carlsson (S)

Q-linea AB, Uppsala, Sweden.

A Cederlöf (A)

Q-linea AB, Uppsala, Sweden.

L Ellis (L)

Q-linea AB, Uppsala, Sweden.

J Melin (J)

Q-linea AB, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH